Spermosens AB (publ) (NGM:SPERM)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.0116
0.00 (0.00%)
At close: Apr 27, 2026
45.00%
Market Cap 36.80M
Revenue (ttm) n/a
Net Income (ttm) -9.20M
Shares Out 3.17B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,254,265
Average Volume 5,609,947
Open 0.0116
Previous Close 0.0116
Day's Range 0.0112 - 0.0116
52-Week Range 0.0042 - 0.0138
Beta -0.05
RSI 76.51
Earnings Date May 7, 2026

About Spermosens AB

Spermosens AB (publ) provides diagnostic health care products and services in Sweden. The company offers devices for male infertility for fertility diagnostics and treatments for the IVF market. It develops JUNO-Checked, a device that measures the binding between sperm and egg cell to enable individualized choice of fertility treatment based on measured binding. Spermosens AB (publ) was incorporated in 2018 and is headquartered in Lund, Sweden. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2018
Employees 4
Stock Exchange Nordic Growth Market
Ticker Symbol SPERM
Full Company Profile

Financial Performance

Financial Statements

News

Spermosens AB Transcript: Status update

Product is ready for clinical validation and regulatory steps, with strong partner interest and a unique market position. Financial runway extends to late July, with licensing deals targeted for H2 2026 and no current plans for rights issues. Ongoing strategic focus is on partnerships, cost control, and value creation.

4 weeks ago - Transcripts